These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30974404)

  • 1. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation.
    Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
    Stem Cell Res; 2019 May; 37():101431. PubMed ID: 30974404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.
    Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
    Stem Cell Res; 2019 May; 37():101437. PubMed ID: 31009818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene.
    Mura M; Lee YK; Ginevrino M; Zappatore R; Pisano F; Boni M; Dagradi F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
    Stem Cell Res; 2018 May; 29():157-161. PubMed ID: 29677589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene.
    Mura M; Pisano F; Stefanello M; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Brink PA; Gnecchi M
    Stem Cell Res; 2019 Apr; 36():101416. PubMed ID: 30878014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
    Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
    Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1.
    Mura M; Ginevrino M; Zappatore R; Pisano F; Boni M; Castelletti S; Crotti L; Valente EM; Schwartz PJ; Gnecchi M
    Stem Cell Res; 2018 May; 29():170-173. PubMed ID: 29684900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying KCNQ1 Mutation and Drug Response in Type 1 Long QT Syndrome Using Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Wei H; Wu J; Liu Z
    Methods Mol Biol; 2018; 1684():7-28. PubMed ID: 29058180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Ma D; Wei H; Lu J; Huang D; Liu Z; Loh LJ; Islam O; Liew R; Shim W; Cook SA
    Stem Cell Res Ther; 2015 Mar; 6(1):39. PubMed ID: 25889101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation.
    Ge N; Liu M; Ding Y; Krawczyk J; McInerney V; Galvin J; Shen S; Prendiville T; O'Brien T
    Stem Cell Res; 2019 Dec; 41():101650. PubMed ID: 31765965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation.
    Lavra L; Magi F; Ulivieri A; Morgante A; Paulis M; Sala L; Pedrazzini M; Polisca P; Rocchetti M; Calò L; Sciacchitano S; Salehi LB
    Stem Cell Res; 2021 Jul; 54():102418. PubMed ID: 34130155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
    Moretti A; Bellin M; Welling A; Jung CB; Lam JT; Bott-Flügel L; Dorn T; Goedel A; Höhnke C; Hofmann F; Seyfarth M; Sinnecker D; Schömig A; Laugwitz KL
    N Engl J Med; 2010 Oct; 363(15):1397-409. PubMed ID: 20660394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease characterization using LQTS-specific induced pluripotent stem cells.
    Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
    Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1.
    Mura M; Bastaroli F; Corli M; Ginevrino M; Calabrò F; Boni M; Crotti L; Valente EM; Schwartz PJ; Gnecchi M
    Stem Cell Res; 2020 Jan; 42():101658. PubMed ID: 31785541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illuminating the potential of pluripotent stem cells.
    Rosenzweig A
    N Engl J Med; 2010 Oct; 363(15):1471-2. PubMed ID: 20925550
    [No Abstract]   [Full Text] [Related]  

  • 17. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
    Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis.
    Ronchi C; Bernardi J; Mura M; Stefanello M; Badone B; Rocchetti M; Crotti L; Brink P; Schwartz PJ; Gnecchi M; Zaza A
    Cardiovasc Res; 2021 Jan; 117(2):472-483. PubMed ID: 32061134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a human induced pluripotent stem cell line, KSCBi015-A, from a long QT syndrome type 1 patient harboring a KCNQ1 mutation.
    Lee Y; Park H; Kyung Koo S; Kim JH
    Stem Cell Res; 2021 Oct; 56():102521. PubMed ID: 34509919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
    Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.